In response to the financial hit many people with diabetes are taking due to the Covid 19 pandemic, Eli Lilly is lowering the cost for most of its insulin products to $35 a month for anyone with commercial insurance or those who lack health coverage altogether. For more information, visit: Eli Lilly Insulin.
There’s a lot of information out there right now about people with diabetes being more susceptible to the coronavirus, but it’s not entirely true. Dr. Edelman explains who is really at risk and why.
Dr. Steven Edelman is one of the nation’s top endocrinologist (diabetes specialist). Dr. Edelman has been a type1 diabetic himself for over 40 years.